David Liebowitz
Plus aucun poste en cours
Profil
David Neal Liebowitz served as a Research Director at Amgen, Inc. and as a Medical Director at Immunex Corp.
He also held positions as Chief Medical Officer at Vaxart, Inc. and Chief Scientific & Medical Officer at Vivaldi Biosciences, Inc. Prior to that, he was an Associate Investigator at the University of Pennsylvania and an Assistant Professor-Medicine & Virology at the University of Chicago.
He also served as the Chief Scientific Officer at Galileo Pharmaceuticals, Inc. from 2004 to 2008.
Liebowitz's education includes undergraduate and graduate degrees from Emory University and a doctorate from the University of Chicago.
Anciens postes connus de David Liebowitz
| Sociétés | Poste | Fin |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
| VAXART, INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Chief Tech/Sci/R&D Officer | 16/12/2008 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Chief Tech/Sci/R&D Officer | - |
| The University of Chicago | Corporate Officer/Principal | - |
Formation de David Liebowitz
| Emory University | Graduate Degree |
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Retail Trade |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
